ME/CFS patients are no strangers to the challenges of accessing treatments for their symptoms.
While there are no FDA-approved medications for ME/CFS, many patients have seen significant symptom improvements with off-label, research-backed treatments.
At RTHM, we are committed to helping you find a path forward.
RTHM provides prescription access to a variety of medications for Long COVID, ME/CFS, POTS and MCAS
LDN modulates the immune system and reduces chronic inflammation, which may alleviate symptoms like fatigue, pain, and brain fog.
By stabilizing mast cells, ketotifen helps reduce allergic-type reactions, providing relief to those with hypersensitivity issues.
Pyridostigmine improves autonomic function, particularly in patients experiencing dysautonomia.
A beta-blocker that helps manage symptoms related to dysautonomia, such as elevated heart rate and anxiety.
By constricting blood vessels and increasing blood pressure, midodrine reduces dizziness and improves daily functioning.
Lowers heart rate without affecting blood pressure, making it ideal for patients with autonomic issues like postural orthostatic tachycardia syndrome (POTS).
By regulating norepinephrine levels in the brain, guanfacine helps with attention, memory, and cognitive clarity.
Not sure which treatment might be right for ME/CFS? Start with RTHM at no cost.
Our free intelligence platform builds a personalized Health Roadmap based on your history, symptoms, and health records—helping highlight which treatments or labs may be most relevant to your case.
@potszebra
"I lost years of my life feeling like I needed a heart transplant. My doctors told me there wasn't a medication that treated POTS and I actually believed them! Until I found RTHM."
"RTHM has been a huge lifeline in a maze of finding out what's happening to my life with Long COVID and effective treatments for such complex, new issues."
"RTHM is peak healthcare and should be used as a blueprint for a new standard of care all over. Thank you for saving me."